Medipyrin (Paracetamol)

Paracetamol works by inhibiting central cyclooxygenase enzymes, which reduces the production of prostaglandins in the brain and spinal cord. This action lowers the body’s temperature set‑point and diminishes the perception of pain, providing both antipyretic and analgesic effects.

The exact dose of Medipyrin is determined by a healthcare professional based on the patient’s age, weight, and clinical condition. The prescriber will set the appropriate amount and frequency, and patients should follow that guidance without exceeding the recommended total daily limit.

Safety data for paracetamol in pregnancy and lactation are limited, and use should only be considered when clearly needed. Women who are pregnant or breastfeeding should consult their physician before taking Medipyrin to weigh potential benefits against any risks.

To order Medipyrin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both Medipyrin (paracetamol) and ibuprofen relieve pain and fever, but ibuprofen also has anti‑inflammatory properties. Paracetamol is generally gentler on the stomach and does not affect platelet function, whereas ibuprofen may cause gastrointestinal irritation and should be avoided in certain cardiovascular conditions.

Medipyrin tablets should be stored at room temperature, below 25 °C, in their original packaging to protect them from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Medipyrin is taken orally with a glass of water. It can be taken with or without food, but if stomach upset occurs, it may be helpful to take the tablet after a meal. The exact administration schedule should follow the prescribing clinician’s instructions.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome, acute liver failure especially after overdose, and rare blood disorders. Prompt medical attention is required if signs of rash, jaundice, unexplained bruising or severe fatigue develop while using the product.

Medipyrin should be avoided by individuals with known hypersensitivity to paracetamol, those with severe liver disease, and patients who are already taking the maximum daily amount of paracetamol from other sources. Children under two months of age should not receive this medication without medical supervision.